https://doi.org/10.4081/reumatismo.2019.1153
Infliximab in the treatment of Budd-Chiari syndrome in Behçet’s disease
Submitted: 1 May 2018
Accepted: 17 July 2019
Published: 24 October 2019
Accepted: 17 July 2019
Abstract Views: 1231
PDF: 763
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Behçet’s disease is a chronic autoinflammatory disorder that usually presents with recurrent oral and genital ulcers, uveitis, skin lesions and arthritis. Any organ, however, can be involved and in a subgroup of patients the large vascular lesions are the predominant feature (vasculo-Behçet disease). We report a case of a 27-yearold man with Behçet’s disease who developed Budd-Chiari syndrome while on immunosuppressive therapy. Infliximab resulted in a rapid and total clinical remission. Literature data have shown that antitumor necrosis factor alpha (anti-TNF-α) agents including infliximab can suppress disease activity but there is no long-term experience on tapering and/or discontinuation of treatment under clinical remission. Our case supports the use of infliximab in vasculo-Behçet patients.
How to Cite
Santos, L., Rigueira, J., & Vilas, A. (2019). Infliximab in the treatment of Budd-Chiari syndrome in Behçet’s disease. Reumatismo, 71(3), 163–165. https://doi.org/10.4081/reumatismo.2019.1153
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita, Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome , Reumatismo: Vol. 59 No. 3 (2007)
- A. Sulli, A. Burroni, M. Tuccio, C. Pizzorni, C. Craviotto, M. Ghio, M. Basso, B. Seriolo, M. Cutolo, Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement , Reumatismo: Vol. 56 No. 1 (2004)
- M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese, Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology , Reumatismo: Vol. 76 No. 3 (2024)
- C. Rizzo, L. La Barbera, A. D’Antonio, F. Camarda, P. Conigliaro, M.S. Chimenti, G. Guggino, The pink side of spondyloarthritis: a narrative review across pathogenesis and clinical manifestations in women , Reumatismo: Vol. 76 No. 3 (2024)
- S. Gülle, A. Çelik, M. Birlik, O. Yılmaz, Skin and lung fibrosis induced by bleomycin in mice: a systematic review , Reumatismo: Vol. 76 No. 1 (2024)
- R. Tanten Zabaleta, J. Marín, J.B. Zacariaz Hereter, J. Maritano, M. Fullana, N. Alvarado, E.R. Soriano, J.E. Rosa, Clinical utility of lung ultrasound for the detection of interstitial lung disease in patients with rheumatoid arthritis , Reumatismo: Early Access
- F. Sari, S. Sari, Cross-cultural adaptation, reliability, and validity of the Turkish version of the Exercise Therapy Burden Questionnaire for individuals with chronic diseases , Reumatismo: Vol. 76 No. 2 (2024)
- E. Lubrano, A. Armuzzi, S. Scriffignano, C. Felice, F.M. Perrotta, V. Venerito, S. Del Vescovo, R. Ramonda, G. Cassone, F. Atzeni, R. Caporali, F. Conti, E. Gremese, F. Iannone, M. Sebastiani, E.G. Favalli, The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease , Reumatismo: Early Access
- M. Carpio Alvarez, A. Cintado Benitez, T. Diaz Argudin, H. Nodarse Cuni, M.d.C Dominguez Horta, J.R. Fernández Massó, Association between COMMD1 gene polymorphism rs11125908 and rheumatoid arthritis in the Cuban population , Reumatismo: Vol. 76 No. 2 (2024)
- E. Yılmaz, Ö. Pasin, Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis , Reumatismo: Early Access
<< < 22 23 24 25 26 27 28 29 30 31 > >>
You may also start an advanced similarity search for this article.
